Medication Safety During Pregnancy: Improving Evidence-Based Practice.

@article{Sinclair2016MedicationSD,
  title={Medication Safety During Pregnancy: Improving Evidence-Based Practice.},
  author={S. Sinclair and Richard K. Miller and C. Chambers and Elizabeth M Cooper},
  journal={Journal of midwifery \& women's health},
  year={2016},
  volume={61 1},
  pages={
          52-67
        }
}
Nearly 90% of women in the United States have taken medications during pregnancy. Medication exposures during pregnancy can result in adverse pregnancy and neonatal outcomes including birth defects, fetal loss, intrauterine growth restriction, prematurity, and longer-term neurodevelopmental outcomes. Advising pregnant women about the safety of medication use during pregnancy is complicated by a lack of data necessary to engage the woman in an informed discussion. Routinely, health care… Expand
Adverse drug reactions in high-risk pregnant women: A prospective study
The 2015 US Food and Drug Administration Pregnancy and Lactation Labeling Rule Symbol
An Ethics Framework for Big Data in Health and Research
...
1
2
...

References

SHOWING 1-10 OF 33 REFERENCES
Better data needed from pregnancy registries.
  • G. Briggs, J. Polifka
  • Medicine
  • Birth defects research. Part A, Clinical and molecular teratology
  • 2009
Evolving knowledge of the teratogenicity of medications in human pregnancy
Prescription drug use in pregnancy.
Birth outcomes in women who have taken leflunomide during pregnancy.
The Ribavirin Pregnancy Registry: Findings after 5 years of enrollment, 2003-2009.
...
1
2
3
4
...